Picard Medical, Inc. (PMI) Shareholder/Analyst Call Prepared Remarks Transcript

Picard Medical, Inc. ( PMI ) Shareholder/Analyst Call July 17, 2026 5:00 PM EDT Company Participants Yuncai Fang - Interim CEO & Chairman of the Board Georgina Smith Matthew Schuster - Chief Operating Officer Presentation Yuncai Fang Interim CEO & Chairman of the Board Good afternoon, everyone, and welcome to the 2026 Annual Meeting of Stockholders of Picard Medical, Inc. My name is Richard Fang, Interim CEO and Chairman of the Board. Thank you for joining us today and for the continued support of Picard Medical. This year's annual meeting is being conducted virtually, allowing stockholders to participate remotely. And now I call meeting to order. Just me, Georgina Smith, Matt Schuster, and myself are representing our management team, and we are joined by our directors, which includes Sam Van, George Ye and Joe Xiao. And also online, we start their representative of Malone Bailey, our Independent Auditor.

Georgina Smith Thank you, Richard. My name is Gina Smith, Chief Accounting Officer. The Board fixed June 26, 2026 as the record date for determining stockholders entitled to vote at this meeting. We have an affidavit of mailing from CST attesting to the fact that Notices of Meeting, proxy statements and 2025 annual reports were mailed to our stockholders of record on June 30, 2026. The purpose of this meeting is to elect 4 directors to serve until the 2027 Annual Meeting of Stockholders. To approve, on an advisory basis, the compensation of our named executive officers. To approve, on an advisory basis, the frequency of our future advisory votes on the compensation of our named executive officers. To approve an amendment to the company's charter. To effect the reverse stock split of our common stock at a ratio to be determined by the board at a ratio ranging from 1 for 15 to 1 for 50. To approve an amendment to the company's charter